Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets open in 1 hour 22 minutes
NIKKEI 225
38,625.75
-7.27
(-0.02%)
HANG SENG
18,030.74
-304.58
(-1.66%)
CRUDE OIL
82.34
+0.17
(+0.21%)
GOLD FUTURES
2,377.10
+8.10
(+0.34%)
DOW
39,134.76
+299.90
(+0.77%)
Bitcoin GBP
50,991.12
-633.40
(-1.23%)
Money
Best UK mortgage deals of the week
Average two-year mortgage deal is now around 6%
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.0800
-0.0200
(-0.95%)
At close: 04:00PM EDT
2.0000
-0.08
(-3.85%)
After hours:
06:26PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
68
130
84,683
10,650
7,756
-
Operating expenses
Research development
181,489
182,945
159,188
138,693
182,243
-
Selling general and administrative
61,198
66,983
117,307
89,057
46,881
-
Total operating expenses
240,095
247,138
271,741
225,426
219,693
-
Operating income or loss
-240,027
-247,008
-187,058
-214,776
-211,937
-
Total other income/expenses net
-14,088
-11,077
-3,113
-36,608
1,526
-
Income before tax
-228,340
-234,632
-183,118
-250,219
-204,472
-
Income from continuing operations
-228,340
-234,632
-183,118
-250,219
-204,472
-
Net income
-228,340
-234,632
-183,118
-250,219
-204,472
-
Net income available to common shareholders
-228,340
-234,632
-183,118
-250,219
-208,054
-
Basic EPS
-0.76
-
-0.74
-1.84
-0.98
-0.62
Diluted EPS
-0.76
-
-0.74
-1.84
-0.98
-0.62
Basic average shares
250,149
-
247,080
135,918
211,746
211,746
Diluted average shares
250,149
-
247,080
135,918
211,746
211,746
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.